Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine-Reference-Cited by-同舟云学术

Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine

Published:2010-10-18 Issue:5 Volume:117 Page:974-981
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Prebet Thomas,Etienne Anne,Devillier Raynier,Romeo Emilie,Charbonnier Aude,D'incan Evelyne,Esterni Benjamin,Arnoulet Christine,Blaise Didier,Vey Norbert

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25554/fullpdf

Reference27 articles.

1. Effect of complete remission on survival in patients with acute myelogenous leukemia receiving first salvage therapy;Vey;Blood.,1999

2. Prognostic index for adult patients with acute myeloid leukemia in first relapse;Breems;J Clin Oncol.,2005

3. Treatment of relapsed and refractory acute myelogenous leukemia;Estey;Leukemia.,2000

4. Biology and management of relapsed acute myeloid leukaemia;Craddock;Br J Haematol.,2005

5. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia;Herzig;J Clin Oncol.,1985

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Benefits and Safety of Gemtuzumab Ozogamicin in Treating Acute Myeloid Leukemia in Various Subgroups: An Updated Systematic Review, Meta-Analysis, and Network Meta-Analysis;Frontiers in Immunology;2021-08-16

2. Factors Associated With Overall Survival in Acute Myeloid Leukemia Patients Before and After Hematopoietic Stem Cell Transplant;Experimental and Clinical Transplantation;2021-08

3. Gemtuzumab Ozogamicin Containing Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia (AML) in Children;Journal of Pediatric Hematology/Oncology;2018-03

4. Gemtuzumab ozogamicin in acute myeloid leukemia;Leukemia;2017-06-13